منابع مشابه
Surrogate insulin-producing cells
Diabetes, a large and growing worldwide health concern, affects the functional mass of the pancreatic beta cell, which in turn affects the glucose regulation of the body. Successful transplantation of cadaveric islets and pancreata for patients with uncontrolled type 1 diabetes has provided proof-of-concept for the development of commercial cell therapy approaches to treat diabetes. Three broad...
متن کاملPromoter optimisation of lentiviral vectors for efficient insulin gene expression in canine mesenchymal stromal cells: potential surrogate beta cells.
BACKGROUND The lack of an ideal cell type that can be easily acquired, modified to produce insulin, and re-implanted has been a limitation for ex vivo insulin gene therapy. Canine diabetes is currently treated with human insulin and is a good model for human diabetes. Mesenchymal stromal cells (MSCs) are a promising candidate cell type for gene therapy. In the present study, we optimised insuli...
متن کاملO20: NK Cells as Surrogate Marker for Predicting Treatment Efficacy in Chronic Inflammatory Demyelinating Polyneuropathy
Natural Killer (NK) cells are part of our innate immune system with regulatory and effector functions. Different studies suggest that treatment with intravenous immunoglobulins (IVIg) has an immunomodulatory effect on NK cells. IVIg is a first-line treatment for various autoimmune diseases in particular in chronic inflammatory demyelinating polyneuropathy (CIDP). The lack of predictive markers ...
متن کاملEndothelial Cells as Surrogate Marker for Angogenesis
4,230,558 A 10/1980 Fulwyler 4,318,846 A 3, 1982 Khanna et al. 4,375.407 A 3, 1983 Kronick 4,452,773. A 6/1984 Molday 4,650,750 A 3, 1987 Giese 4,795,698 A 1, 1989 Owen et al. 4,811,218 A 3/1989 Hunkapiller et al. 4,943,533 A 7, 1990 Mendelsohn et al. 4,997,928 A 3/1991 Hobbs, Jr. 5,096,815 A 3, 1992 Ladner et al. 5, 183,884 A 2f1993 Kraus et al. 5,194,596 A * 3/1993 Tischer et al. ...............
متن کاملReview on Interferon beta: from cells to clinical usage
Introduction: Interferon (IFN) was first introduced by Isaacs and Linddeman in 1957. It referred to a factor that could cause inhibition in the growth of the live influenza virus. Interferons are intracellular proteins that are involved in many cellular processes such as growth, proliferation, differentiation, metabolism of the extracellular matrix, apoptosis, and regulating immune responses. T...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Diabetologia
سال: 1997
ISSN: 0012-186X,1432-0428
DOI: 10.1007/bf03168185